Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs PARENT.DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHUKRA PHARMA PARENT.DRUGS SHUKRA PHARMA/
PARENT.DRUGS
 
P/E (TTM) x 19.3 -0.1 - View Chart
P/BV x 14.1 - - View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHUKRA PHARMA   PARENT.DRUGS
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-23
PARENT.DRUGS
Mar-21
SHUKRA PHARMA/
PARENT.DRUGS
5-Yr Chart
Click to enlarge
High Rs893 2,798.1%   
Low Rs113 427.7%   
Sales per share (Unadj.) Rs53.74.1 1,315.5%  
Earnings per share (Unadj.) Rs4.0-40.8 -9.9%  
Cash flow per share (Unadj.) Rs5.7-35.0 -16.3%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs23.1-229.0 -10.1%  
Shares outstanding (eoy) m10.9629.82 36.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.90.7 131.5%   
Avg P/E ratio x12.4-0.1 -17,565.0%  
P/CF ratio (eoy) x8.8-0.1 -10,631.3%  
Price / Book Value ratio x2.20 -17,166.5%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m54786 635.9%   
No. of employees `000NANA-   
Total wages/salary Rs m44145 30.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m588122 483.5%  
Other income Rs m121 1,870.3%   
Total revenues Rs m600122 490.8%   
Gross profit Rs m54-118 -45.6%  
Depreciation Rs m18173 10.6%   
Interest Rs m31,254 0.2%   
Profit before tax Rs m44-1,545 -2.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0-328 -0.1%   
Profit after tax Rs m44-1,217 -3.6%  
Gross profit margin %9.1-96.8 -9.4%  
Effective tax rate %0.821.2 3.7%   
Net profit margin %7.5-1,000.3 -0.7%  
BALANCE SHEET DATA
Current assets Rs m531681 78.0%   
Current liabilities Rs m42511,436 3.7%   
Net working cap to sales %18.0-8,839.3 -0.2%  
Current ratio x1.20.1 2,097.6%  
Inventory Days Days0375 0.0%  
Debtors Days Days1,8730-  
Net fixed assets Rs m2193,343 6.5%   
Share capital Rs m39298 13.1%   
"Free" reserves Rs m214-7,127 -3.0%   
Net worth Rs m253-6,829 -3.7%   
Long term debt Rs m381,072 3.5%   
Total assets Rs m7504,024 18.6%  
Interest coverage x16.8-0.2 -7,261.3%   
Debt to equity ratio x0.1-0.2 -94.9%  
Sales to assets ratio x0.80 2,595.2%   
Return on assets %6.30.9 675.6%  
Return on equity %17.417.8 97.7%  
Return on capital %16.25.0 322.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m321,253 2.5%  
From Investments Rs m-441 -7,140.3%  
From Financial Activity Rs m49-1,254 -3.9%  
Net Cashflow Rs m37-1 -7,223.5%  

Share Holding

Indian Promoters % 51.0 73.3 69.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 0.0 1,100.0%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 26.7 183.6%  
Shareholders   10,963 7,129 153.8%  
Pledged promoter(s) holding % 0.0 94.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHUKRA PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RELISH PHARMA vs PARENT.DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RELISH PHARMA vs PARENT.DRUGS Share Price Performance

Period RELISH PHARMA PARENT.DRUGS S&P BSE HEALTHCARE
1-Day -2.00% 4.63% 1.18%
1-Month 18.32% 9.71% -0.75%
1-Year 528.10% -19.48% 61.82%
3-Year CAGR 229.50% 8.97% 18.16%
5-Year CAGR 114.18% -19.84% 19.79%

* Compound Annual Growth Rate

Here are more details on the RELISH PHARMA share price and the PARENT.DRUGS share price.

Moving on to shareholding structures...

The promoters of RELISH PHARMA hold a 51.0% stake in the company. In case of PARENT.DRUGS the stake stands at 73.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RELISH PHARMA and the shareholding pattern of PARENT.DRUGS.

Finally, a word on dividends...

In the most recent financial year, RELISH PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 12.4%.

PARENT.DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of RELISH PHARMA, and the dividend history of PARENT.DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.